Generic drugs-increase in employment

Also, the use of generic drugs contributes to the growth of employment.

Generic drug manufacturers in Europe operate in advanced research laboratories and production facilities run by highly qualified personnel. Companies typically invest 6-16% of their revenue (and in some cases up to 30%) in research and development of new products.

In a number of EU countries, companies producing generic medicines are the main suppliers of medicines in their market.

In addition, European manufacturers are the world's leading exporters of quality generic active ingredients, contributing to a positive trade balance in Europe.